Publications by authors named "M Congo-Ouedraogo"
Article Synopsis
- * A study conducted in 2016-2017 involved oropharyngeal swabs from 13,758 participants to identify circulating meningococcal strains, revealing that 90.2% of the isolates were non-groupable, mainly from clonal complex 192 (CC192).
- * The study found groupable isolates from recent outbreak-associated clonal complexes (CC11 and CC10217) and highlights the necessity of carriage studies for understanding and managing meningococcal
Article Synopsis
- A nationwide vaccination campaign with the MenAfriVac meningococcal serogroup A vaccine in Burkina Faso significantly reduced the carriage and disease of serogroup A Neisseria meningitidis in the first two years and is assessed for its long-term impact.
- Cross-sectional studies conducted from May 2016 to November 2017 included nearly 14,300 participants aged 9 months to 36 years, revealing a 7.60% prevalence of meningococcal carriage without any cases of serogroup A.
- The study indicates that the MenAfriVac vaccine continues to effectively reduce serogroup A carriage for at least 7 years, while carriage of other serogroups remains low, highlighting the
Background: To better understand how to prevent and respond to pneumococcal meningitis outbreaks in the meningitis belt, we retrospectively examined Burkina Faso's case-based meningitis surveillance data for pneumococcal meningitis clusters and assessed potential usefulness of response strategies.
Methods: Demographic and clinical information, and cerebrospinal fluid laboratory results for meningitis cases were collected through nationwide surveillance. Pneumococcal cases were confirmed by culture, polymerase chain reaction (PCR), or latex agglutination; strains were serotyped using PCR.
Background: In 2013, Burkina Faso introduced 13-valent pneumococcal conjugate vaccine (PCV13) into the routine childhood immunization program, to be administered to children at 8, 12, and 16 weeks of age. We evaluated the impact of PCV13 on pneumococcal meningitis.
Methods: Using nationwide surveillance, we gathered demographic/clinical information and cerebrospinal fluid (CSF) results for meningitis cases.